BioProcess International Convention
Join us virtually or in-person in Boston, MA for the BioProcess International Convention where Just-Evotec Biologics will be presenting.
- Randal Bass, SVP Biotherapeutic Process & Product Design at Just-Evotec Biologics
- Woo Chi, Principal Scientist Process Design at Just-Evotec Biologics
- Todd Ireland, Senior Director Business Development at Just-Evotec Biologics
Presentation | 30 September at 8:30am EST
How AI, ML and continuous manufacturing technologies can drive flexible biomanufacturing: the J.POD® facility example
During this session, Randal Bass will present how AI and ML-based technologies can support the discovery and design of biotherapeutic molecules, making them more “developable” and optimized for biomanufacturing. Impacts on yield, quality, purification, formulation, stability, PK, will be discussed. He will also describe the innovative and disruptive J.POD® facility concept which relies on the use of intensified/continuous manufacturing processes combined with the high flexibility of production capabilities. The added-value of the J.POD® facility concept in terms of productivity gain, cost optimization, supply chain quality and reliability but also rapid deployment of additional capacities will be addressed.
Presented by Randal Bass, SVP Biotherapeutic Process & Product Design at Just-Evotec Biologics
Presentation | 27 September at 12:00pm EST
Accelerating cell line development process through automation platform integration
Traditional cell line development process often requires manual handling of cells, a slow process that is prone to human errors. Based on prior experience, we are rolling out a relatively simple automation platform integrating a liquid handling robot, cell counter, centrifuge, and incubation capabilities for an accurate, high-throughput, and expedited CLD process that requires minimal intervention for selecting the best candidate clones. The latest advancement of this automation platform integration will be discussed.
Presented by Woo Chi, Principal Scientist Process Design at Just-Evotec Biologics
Randal BassSVP Biotherapeutic Process & Product Design
Dr. Randal Bass is responsible for upstream, downstream and analytical development activities at Just. Randal began his 12+ year career in industry at Amgen, joining the Analytical Sciences department, where he led analytical and cross-functional process teams. Most recently, Randal served as a director of Process Development overseeing the Washington site Analytical Sciences function.
Randal has broad experience developing large molecule therapeutics, both novel and biosimilars, from early stage First in Human, to commercialization through post-launch support and second generation commercial processes. He has been an author of numerous regulatory filings to the FDA, EMA, PMDA and many other agencies. With pivotal, commercial, and post-launch filings, these included a heavy emphasis on establishing comparability or biosimilarity for numerous molecules. Randal’s interaction with regulators includes both written and face-to-face meetings with multiple agencies. Randal received his Ph.D. from the University of Colorado in Biochemistry with a focus on membrane protein biochemistry and biophysics, and completed a postdoctoral fellowship at the California Institute of Technology in X-ray crystallography of ion channels.
Woo ChiPrincipal Scientist Process
Woo Chi is a principal scientist at Just – Evotec Biologics and leads a newly formed cell line development team to guide client project development, process optimization and integration of automation platform. Woo started his career in cell line development at AbbVie as a contingent scientist in 2015, contributing to CHO platform development. He continued his career at Zoetis, developing cell lines for pipeline production and engaging on numerous tech development initiatives. Woo earned his Ph.D. in Genetics at Yale University on germ cell development and had his postdoc training at Harvard University on biology of the hair follicle.